Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)

This grant opportunity, RFA-DA-26-034, seeks basic research proposals on the deleterious effects of acute exposure to ultra-potent synthetic opioids. Clinical trials are not allowed under this R01 grant, which falls under the Chemical Countermeasures Research Program (CCRP) Initiative.